CAD 0.05
(-28.57%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - CAD | -100.0% |
2022 | 26.96 Thousand CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2024 Q3 | - CAD | 0.0% |
2023 FY | - CAD | -100.0% |
2023 Q4 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | -100.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q4 | 3173.00 CAD | -86.67% |
2022 Q3 | 23.79 Thousand CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 FY | 26.96 Thousand CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Biosenta Inc. | 1042.00 CAD | 100.0% |